Ixazomib-13C2,15N is 13C and 15N labeled Ixazomib. Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (beta5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM)[1].
Molecular Weight:
364.01
Formula:
C12 13C2H19BCl2N 15NO4
Target:
Autophagy,Isotope-Labeled Compounds,Proteasome
Application Notes:
MCE Product type: Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted
